Clinical Trial Update: Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response [Phase 2]

View source ↗

Summary

A Phase 2 randomized controlled trial is assessing Cistanche total glycosides for amyotrophic lateral sclerosis; no results or status details are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Cistanche Total Glycosides (total glycosides of Cistanche)

Snippet

Sponsor: Peking University | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: UNKNOWN